Probably right. Interesting how it sinks on good news. Moving into phase 2 for a lesser company would probably send that stock to significant gains but for THLD , nothing . Still lots of manipulation in my opinion . Little Timmy will pipe in and say its just the way the " market " values the company , and that there is no interest from " serious " hedge funds and biotech institutional investors blah blah blah.